Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

NCT03258099 is registered in ClinicalTrials.gov with Cui Yimin as lead sponsor.

NCT NCT03258099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Lead sponsor
Cui Yimin
Phase
Observational
Overall status
Unknown status
Start date
December 28, 2017
Completion date
December 31, 2019
Enrollment
2,200 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

capecitabine, drug-related side effects and adverse reactions, pharmacogenetics, pharmacokinetics, solid tumor